🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/02/2023 | 71,96 | 74,60 | 71,60 | 73,67 | +3,06% | 4,17% | 120.600 |
| 16/02/2023 | 72,43 | 74,26 | 71,47 | 71,48 | -2,06% | 3,85% | 69.700 |
| 15/02/2023 | 70,91 | 73,13 | 69,70 | 72,98 | +2,43% | 4,84% | 109.900 |
| 14/02/2023 | 71,29 | 71,62 | 69,36 | 71,25 | -0,06% | 3,17% | 102.100 |
| 13/02/2023 | 70,04 | 71,64 | 68,33 | 71,29 | +1,71% | 4,73% | 110.900 |
| 10/02/2023 | 69,78 | 70,32 | 67,20 | 70,09 | +0,26% | 4,47% | 137.600 |
| 09/02/2023 | 70,85 | 71,40 | 69,31 | 69,91 | -1,19% | 2,95% | 95.500 |
| 08/02/2023 | 72,12 | 72,60 | 70,75 | 70,75 | -2,62% | 2,57% | 66.500 |
| 07/02/2023 | 71,30 | 72,81 | 70,81 | 72,65 | +1,35% | 2,81% | 89.600 |
| 06/02/2023 | 71,14 | 72,99 | 71,14 | 71,68 | +0,32% | 2,60% | 85.800 |
| 03/02/2023 | 69,45 | 72,49 | 69,45 | 71,45 | +2,00% | 4,38% | 152.600 |
| 02/02/2023 | 70,96 | 71,78 | 68,66 | 70,05 | -0,85% | 4,40% | 112.300 |
| 01/02/2023 | 69,72 | 71,37 | 68,10 | 70,65 | +1,36% | 4,69% | 84.300 |
| 31/01/2023 | 68,47 | 69,88 | 68,35 | 69,70 | +2,26% | 2,23% | 67.600 |
| 30/01/2023 | 69,75 | 70,31 | 68,05 | 68,16 | -3,03% | 3,24% | 64.700 |
| 27/01/2023 | 69,98 | 71,89 | 69,98 | 70,29 | +0,82% | 2,73% | 62.800 |
| 26/01/2023 | 76,96 | 78,00 | 69,00 | 69,72 | -8,99% | 11,69% | 186.100 |
| 25/01/2023 | 72,05 | 76,84 | 71,43 | 76,61 | +5,41% | 7,51% | 172.700 |
| 24/01/2023 | 71,00 | 72,71 | 70,25 | 72,68 | +2,22% | 3,46% | 85.200 |
| 23/01/2023 | 70,39 | 71,16 | 69,56 | 71,10 | +0,97% | 2,27% | 94.400 |
| 20/01/2023 | 71,25 | 71,25 | 69,69 | 70,42 | -0,66% | 2,19% | 62.600 |
| 19/01/2023 | 70,36 | 71,16 | 69,43 | 70,89 | +0,04% | 2,46% | 71.700 |
| 18/01/2023 | 71,00 | 72,05 | 69,97 | 70,86 | -0,13% | 2,93% | 146.200 |
| 17/01/2023 | 70,99 | 71,20 | 69,61 | 70,95 | -0,46% | 2,24% | 103.700 |
| 13/01/2023 | 70,04 | 71,59 | 70,04 | 71,28 | +0,81% | 2,21% | 99.700 |
| 12/01/2023 | 68,95 | 70,85 | 67,67 | 70,71 | +2,69% | 4,61% | 129.500 |
| 11/01/2023 | 67,62 | 69,28 | 67,62 | 68,86 | +1,47% | 2,45% | 105.100 |
| 10/01/2023 | 67,17 | 68,35 | 66,74 | 67,86 | +1,24% | 2,40% | 81.200 |
| 09/01/2023 | 67,12 | 67,49 | 66,14 | 67,03 | +0,51% | 2,01% | 154.000 |
| 06/01/2023 | 66,58 | 67,63 | 65,80 | 66,69 | +0,76% | 2,75% | 84.500 |